Trial Profile

Panitumumab after Resection of Liver Metastases from Colorectal Cancer in RAS Wild-type Patients - PARLIM

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Panitumumab (Primary) ; Fluorouracil; Folic acid; Oxaliplatin
Indications Colorectal cancer; Liver metastases
Focus Therapeutic Use
Acronyms PARLIM

Most Recent Events

02 Feb 2023 This trial has been completed in Germany, according to European Clinical Trials Database record.
12 Aug 2022 Results assessing the efficacy of panitumumab plus FOLFOX or FOLFOX alone as additive therapy for colorectal cancer liver metastases published in the European Journal of Cancer.
08 Jun 2021 Status changed from recruiting to completed, results presented at the 57th Annual Meeting of the American Society of Clinical Oncology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com